Dermatology 2013

Notes: Barbosa, Naiara S

Kalaaji, Amer N

eng

Review

England

2014/01/21 06:00

Complement Ther Clin Pract. 2014 Feb;20(1):11-5. doi: 10.1016/j.ctcp.2013.11.003. Epub 2013 Nov 20.

URL: http://www.ncbi.nlm.nih.gov/pubmed/24439638

Author Address: Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA. Electronic address: barbosa.naiara@mayo.edu.

Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA. Electronic address: kalaaji.amer@mayo.edu.

 

 

Reference Type:  Journal Article

Record Number: 4280Author: Basset-Seguin, N.

Year: 2013

Title: [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]

Journal: Ann Dermatol Venereol

Volume: 140 Suppl 2

Pages: 223-8

Date: Nov

Short Title: [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]

Alternate Journal: Annales de dermatologie et de venereologie

ISSN: 0151-9638 (Print)

0151-9638 (Linking)

DOI: 10.1016/S0151-9638(13)70138-8

Original Publication: Revue Panoramique de la PDT. Principe, photo-sensibilisateurs, sources de lumieres et indications validees en dermatologie.

Accession Number: 24199714

Keywords: Aminolevulinic Acid/analogs & derivatives/therapeutic use

Bowen’s Disease/drug therapy

Carcinoma, Basal Cell/drug therapy

Clinical Trials as Topic

Humans

Keratosis, Actinic/drug therapy

Pain/etiology

*Photochemotherapy/adverse effects/instrumentation/methods

Photosensitizing Agents/therapeutic use

Practice Guidelines as Topic

Precancerous Conditions/drug therapy

Skin Diseases/*drug therapy

Skin Neoplasms/drug therapy

Abstract: INTRODUCTION: Photodynamic therapy (PDT) combines the use of a topical sensitizer and its excitation with a light of appropriate wavelength. Its use in dermatooncology has been possible in France in 2006 when the methyl ester ALA or Metvixia(R) got approved. OBJECTIVE: To provide a panoramic view of validated indications of PDT in oncodermatology. METHOD: This work is based on the review of the literature as well as available guidelines or recommendation on PDT in dermatology. RESULTS: Standardized protocols and results of the main clinical trials are given for the three major indications in dermatology: actinic keratosis, basal cell carcinoma and Bowen disease. CONCLUSION: PDT has its role to play in the treatment of multiple superficial carcinomas and cutaneous precancerous lesions and its main advantage resides in its optimal healing.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295